chapter 1 7 pharmacology - brainspew.combrainspew.com/advanced/medic/slides/chapter_017.pdf ·...
TRANSCRIPT
1
Chapter 17Chapter 17PharmacologyPharmacology
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
ObjectivesObjectivesExplain what a drug isExplain what a drug is
Identify four types of drug namesIdentify four types of drug names
Outline drug standards and legislationOutline drug standards and legislation
Describe the paramedicDescribe the paramedic’’s responsibilities in drug s responsibilities in drug administrationadministration
Distinguish among drug formsDistinguish among drug forms
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
ObjectivesObjectives
Outline autonomic nervous system functions Outline autonomic nervous system functions that may be changed with drug therapythat may be changed with drug therapy
Discuss factors that influence drug absorption, Discuss factors that influence drug absorption, distribution, eliminationdistribution, elimination
Describe how drugs react with receptors to Describe how drugs react with receptors to produce their desired effectsproduce their desired effects
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Mosby, Inc. items and derived items © 2007, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
Sanders: Mosby's Paramedic Textbook, Revised 3rd Edition PowerPoint Lecture Notes
Chapter 17: Pharmacology
2
ObjectivesObjectivesList variables that can influence drug interactionsList variables that can influence drug interactions
Identify considerations for drug administration to Identify considerations for drug administration to pregnant, pediatric, and older patientspregnant, pediatric, and older patients
Outline drug actions for patient who is given drugs that Outline drug actions for patient who is given drugs that affect body systemsaffect body systems
Explain meaning of drug terms used in drug referencesExplain meaning of drug terms used in drug references
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
ScenarioScenarioAn 80An 80--yearyear--old woman has fallen and is old woman has fallen and is experiencing severe pain. You observe experiencing severe pain. You observe obvious deformity of the hip. Her husband obvious deformity of the hip. Her husband hands you a sack that contains her pill hands you a sack that contains her pill bottles, but he is too upset to tell you what bottles, but he is too upset to tell you what she is being treated for.she is being treated for.
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
DiscussionDiscussionWhy is it important to understand the general Why is it important to understand the general actions of her home medications?actions of her home medications?
What additional information will you need to What additional information will you need to obtain prior to treating her pain?obtain prior to treating her pain?
How will the age of this patient affect your drug How will the age of this patient affect your drug administration?administration?
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Mosby, Inc. items and derived items © 2007, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
3
Ancient Health CareAncient Health CarePharmacology dates to 10,000 to 7,000 B.C. Pharmacology dates to 10,000 to 7,000 B.C.
Medicinal herbsMedicinal herbs
Medications mentioned in BibleMedications mentioned in Bible
PlantPlant--derived drugs used in Middle Agesderived drugs used in Middle Ages
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Historical Trends in PharmacologyHistorical Trends in Pharmacology
““Chemical medicineChemical medicine”” born in 17born in 17thth centurycentury
Studies of drug dosage in 19Studies of drug dosage in 19thth centurycenturyLed to development of manufacturing plants to Led to development of manufacturing plants to produce drugsproduce drugs
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Modern Health CareModern Health CareExpansion of consumer health education Expansion of consumer health education
Increased researchIncreased research
Incentives to develop orphan drugs for Incentives to develop orphan drugs for treatment of rare, chronic diseasestreatment of rare, chronic diseases
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Mosby, Inc. items and derived items © 2007, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
4
DrugsDrugsDefined as:Defined as:
Any substance taken by mouth; injected into a Any substance taken by mouth; injected into a muscle, blood vessel, or cavity of the body; muscle, blood vessel, or cavity of the body; inhaled; or applied topically to treat or prevent a inhaled; or applied topically to treat or prevent a disease or conditiondisease or condition
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Sources of DrugsSources of DrugsFive major sourcesFive major sources
Plants (alkaloids, glycosides, gums, and oils)Plants (alkaloids, glycosides, gums, and oils)Animals and humansAnimals and humansMinerals or mineral productsMinerals or mineral productsMicroorganismsMicroorganismsChemical substances made in laboratoryChemical substances made in laboratory
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Drug NamesDrug NamesChemical nameChemical name
Generic name Generic name Nonproprietary nameNonproprietary name
Trade name Trade name Brand or proprietary nameBrand or proprietary name
Official nameOfficial name
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Mosby, Inc. items and derived items © 2007, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
5
Drug ReferencesDrug ReferencesAmerican Medical American Medical Association (AMA) Drug Association (AMA) Drug EvaluationEvaluation
American Hospital Formulary American Hospital Formulary Service (AHFS)Service (AHFS)
Medication package insertsMedication package inserts
MosbyMosby’’s Drug Consults Drug Consult
Physician's Desk ReferencePhysician's Desk Reference(PDR)(PDR)
Nursing Drug ReferenceNursing Drug Reference(NDR)(NDR)
Electronic data basesElectronic data basesFDA web pageFDA web pageMedlineMedlinePharmInfoNet web pagePharmInfoNet web pageToxlineToxline
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Drug Standards and LegislationDrug Standards and Legislation
Before 1906: Little controlBefore 1906: Little controlPure Food and Drug Act, 1906Pure Food and Drug Act, 1906Shirley Amendment, 1912Shirley Amendment, 1912Harrison Narcotic Act, 1914Harrison Narcotic Act, 1914Federal Food, Drug, and Cosmetic Act, 1938Federal Food, Drug, and Cosmetic Act, 1938DurhamDurham--Humphrey Amendment, 1952Humphrey Amendment, 1952KefauverKefauver--Harris Amendment, 1962Harris Amendment, 1962
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Comprehensive Drug Abuse Comprehensive Drug Abuse Prevention and Control Act, 1970Prevention and Control Act, 1970
Also called the Controlled Substances Act (CSA)Also called the Controlled Substances Act (CSA)Superseded Harrison Narcotic Act of 1914Superseded Harrison Narcotic Act of 1914
Classified drugs into five categories (schedules) Classified drugs into five categories (schedules) based on:based on:
Potential for abuse and physical and psychological Potential for abuse and physical and psychological dependencedependenceDefined terms Defined terms drug dependencydrug dependency and and drug addictiondrug addictionEstablished education and treatment programs for drug Established education and treatment programs for drug abuse abuse
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Mosby, Inc. items and derived items © 2007, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
6
Drug SchedulesDrug SchedulesSchedule ISchedule I
High abuse potentialHigh abuse potentialNo accepted medical useNo accepted medical use
Schedule IISchedule IIHigh abuse potentialHigh abuse potentialAccepted medical usesAccepted medical uses
Schedule IIISchedule IIILess abuse potential than drugs in schedules I and IILess abuse potential than drugs in schedules I and IIAccepted medical uses; may lead to some physical Accepted medical uses; may lead to some physical dependence or high psychological dependencedependence or high psychological dependence
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Drug SchedulesDrug Schedules
Schedule IVSchedule IVLower abuse potential than schedule III drugsLower abuse potential than schedule III drugsAccepted medical uses; may lead to limited physical or Accepted medical uses; may lead to limited physical or psychological dependencepsychological dependence
Schedule VSchedule VLow abuse potential compared to schedule IV drugsLow abuse potential compared to schedule IV drugsAccepted medical uses; may lead to limited physical or Accepted medical uses; may lead to limited physical or psychological dependencepsychological dependence
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Drug Regulatory AgenciesDrug Regulatory AgenciesIn 1973 the Drug Enforcement Agency (DEA) In 1973 the Drug Enforcement Agency (DEA) became the sole drug enforcement organization in became the sole drug enforcement organization in the U.S.the U.S.
Other regulatory bodies or servicesOther regulatory bodies or servicesFood and Drug AdministrationFood and Drug AdministrationPublic Health ServicePublic Health ServiceFederal Trade CommissionFederal Trade CommissionCanadian drug controlCanadian drug controlInternational drug control International drug control
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Mosby, Inc. items and derived items © 2007, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
7
General Properties of DrugsGeneral Properties of DrugsTherapeutic effectsTherapeutic effects
Desirable drug actionsDesirable drug actions
Side effectsSide effectsUndesirable or harmful drug actionsUndesirable or harmful drug actions
Drug interaction with other drugsDrug interaction with other drugsCan produce unpredictable effectsCan produce unpredictable effects
Drug actions are biochemical interaction between Drug actions are biochemical interaction between drug and tissue componentsdrug and tissue components
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Pharmaceutical PhasePharmaceutical PhasePharmaceuticsPharmaceutics
Science of dispensing drugsScience of dispensing drugs
DissolutionDissolutionRate at which a solid drug goes into solution after Rate at which a solid drug goes into solution after ingestioningestionMore rapid rate of dissolution = more quickly drug More rapid rate of dissolution = more quickly drug is absorbedis absorbed
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Pharmacokinetic PhasePharmacokinetic PhasePharmacokineticsPharmacokinetics
How the body handles a drug over a period of timeHow the body handles a drug over a period of time•• AbsorptionAbsorption•• DistributionDistribution•• BiotransformationBiotransformation•• ExcretionExcretion
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Mosby, Inc. items and derived items © 2007, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
8
Drug AbsorptionDrug AbsorptionMovement of drug molecules from site of Movement of drug molecules from site of entry to general circulationentry to general circulation
Variables affecting drug absorptionVariables affecting drug absorptionAbsorbing surfaceAbsorbing surfaceBlood flow to the administration siteBlood flow to the administration siteDrug solubilityDrug solubilitypHpHDrug concentrationDrug concentrationDosage formDosage form
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Routes of Medication AdministrationRoutes of Medication Administration
Mode affects the rate of onset of actionMode affects the rate of onset of actionMay affect the therapeutic response May affect the therapeutic response
Drugs are given for local or systemic effectsDrugs are given for local or systemic effects
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Routes of Medication AdministrationRoutes of Medication Administration
TopicalTopical
Enteral Enteral
PulmonaryPulmonary
ParenteralParenteral
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Mosby, Inc. items and derived items © 2007, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
9
Enteral RouteEnteral RouteDrugs administered along GI tractDrugs administered along GI tract
OralOralRectalRectalNasogastricNasogastric
Safe, convenient, economical Safe, convenient, economical
Least reliable and slowest route Least reliable and slowest route Food contentsFood contentsEmotional stateEmotional statePhysical activityPhysical activity
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Oral AbsorptionOral AbsorptionRich blood supply, little absorption in mouthRich blood supply, little absorption in mouth
Nitroglycerin and some hormones Nitroglycerin and some hormones administered by sublingual or buccal routesadministered by sublingual or buccal routes
Rapidly dissolve in salivary secretionsRapidly dissolve in salivary secretions
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Gastric AbsorptionGastric AbsorptionLength of time a drug remains in the stomach Length of time a drug remains in the stomach varies depending on:varies depending on:
pH of the environmentpH of the environmentGastric motilityGastric motility
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Mosby, Inc. items and derived items © 2007, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
10
Absorption in the Small Intestine Absorption in the Small Intestine
Rich blood supply and large absorption areaRich blood supply and large absorption areaMost drug absorption occurs in the upper portion Most drug absorption occurs in the upper portion of the small intestineof the small intestine
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Rectal AbsorptionRectal AbsorptionEffective for some medicationsEffective for some medications
Vascular surface area capable of drug absorptionVascular surface area capable of drug absorption
Erratic absorption may occur from:Erratic absorption may occur from:Rectal contentsRectal contentsLocal drug irritationLocal drug irritationUncertainty of drug retentionUncertainty of drug retention
No hepatic alteration on first pass through bodyNo hepatic alteration on first pass through body
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Parenteral AdministrationParenteral Administration
SubcutaneousSubcutaneousIntramuscularIntramuscularIntravenousIntravenousIntradermalIntradermalIntraosseousIntraosseousEndotrachealEndotracheal
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Mosby, Inc. items and derived items © 2007, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
11
Subcutaneous AdministrationSubcutaneous AdministrationAn injection beneath skin into connective An injection beneath skin into connective tissue or fat beneath dermistissue or fat beneath dermis
Used for small volumes of drugs (Used for small volumes of drugs (<<0.5 mL) that do 0.5 mL) that do not irritate tissuenot irritate tissueAbsorption rate is slow Absorption rate is slow Can provide sustained effect Can provide sustained effect
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Intramuscular AdministrationIntramuscular AdministrationInjection given into skeletal muscleInjection given into skeletal muscle
Absorption occurs more rapidly than SC injection Absorption occurs more rapidly than SC injection Greater tissue blood flow Greater tissue blood flow
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Intravenous AdministrationIntravenous AdministrationAn injection given directly into the bloodstreamAn injection given directly into the bloodstream
Bypasses absorption processBypasses absorption process
Almost immediate effectAlmost immediate effect
Most IV drugs are administered slowly to help Most IV drugs are administered slowly to help prevent adverse reactionsprevent adverse reactions
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Mosby, Inc. items and derived items © 2007, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
12
Intradermal AdministrationIntradermal AdministrationInjection just below the epidermisInjection just below the epidermis
Primarily used for allergy testing and to Primarily used for allergy testing and to administer local anestheticsadminister local anesthetics
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Intraosseous AdministrationIntraosseous AdministrationAn injection directly into the bone marrow An injection directly into the bone marrow cavity through an IO infusion systemcavity through an IO infusion system
Agents circulate via boneAgents circulate via bone’’s medullary cavitys medullary cavity
Time from injection to onset of action similar Time from injection to onset of action similar to venous routeto venous route
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Endotracheal Administration Endotracheal Administration Generally through an ET tubeGenerally through an ET tube
Drug delivery into the pulmonary alveoli Drug delivery into the pulmonary alveoli
Systemic absorption via lung capillariesSystemic absorption via lung capillaries
Absorption almost as rapid as IV routeAbsorption almost as rapid as IV route
Usually reserved for situations in which an IV line Usually reserved for situations in which an IV line cannot be establishedcannot be established
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Mosby, Inc. items and derived items © 2007, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
13
Endotracheal AdministrationEndotracheal AdministrationAdult ET medications include:Adult ET medications include:
Lidocaine (Xylocaine)Lidocaine (Xylocaine)Epinephrine (Adrenalin)Epinephrine (Adrenalin)AtropineAtropineNaloxone (Narcan)Naloxone (Narcan)
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Pulmonary RoutePulmonary RouteDrugs given by gas or fine mist (aerosol)Drugs given by gas or fine mist (aerosol)
Absorption in blood is rapid due to:Absorption in blood is rapid due to:Large surface areaLarge surface areaRich alveolar capillary networkRich alveolar capillary network
Produces primarily local effectsProduces primarily local effects
Occasionally unwanted systemic effectsOccasionally unwanted systemic effects
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Topical RouteTopical RouteDrugs applied topically to skin and mucous Drugs applied topically to skin and mucous membranesmembranes
Usually rapidly absorbed to produce a local Usually rapidly absorbed to produce a local effecteffect
Only intact skin surfaces used to prevent Only intact skin surfaces used to prevent systemic effectssystemic effects
Massaging skin promotes drug absorptionMassaging skin promotes drug absorption
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Mosby, Inc. items and derived items © 2007, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
14
Drug DistributionDrug Distribution
Transport of a drug through the bloodstream Transport of a drug through the bloodstream to body tissues and site of actionto body tissues and site of action
Distribution rate depends on capillary Distribution rate depends on capillary permeability to drugpermeability to drug
Cardiac output and regional blood flow affect Cardiac output and regional blood flow affect rate and extent of distributionrate and extent of distribution
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Drug ReservoirsDrug Reservoirs
Drugs accumulate at storage sites, form Drugs accumulate at storage sites, form reservoirs by binding to specific tissuesreservoirs by binding to specific tissues
Two types of drug reservoirs:Two types of drug reservoirs:Plasma protein bindingPlasma protein bindingTissue bindingTissue binding
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
BloodBlood--Brain BarrierBrain BarrierSingle layer of capillary endothelial cellsSingle layer of capillary endothelial cells
Line blood vessels entering the CNSLine blood vessels entering the CNSPermits only lipidPermits only lipid--soluble drugs to be distributed soluble drugs to be distributed into brain and CSF into brain and CSF
•• e.g., general anesthetics and barbituratese.g., general anesthetics and barbituratesDrugs poorly soluble in fat have trouble passing Drugs poorly soluble in fat have trouble passing this barrier this barrier Cannot enter the brainCannot enter the brain
•• e.g., many antibioticse.g., many antibiotics
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Mosby, Inc. items and derived items © 2007, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
15
Placental BarrierPlacental BarrierMembrane layers separate blood vessels of Membrane layers separate blood vessels of mother and fetusmother and fetus
Not permeable to many lipidNot permeable to many lipid--insoluble drugsinsoluble drugs
Provides some protection to the fetusProvides some protection to the fetusAllows passage of certain nonAllows passage of certain non--lipidlipid--soluble drugssoluble drugs
•• Steroids, narcotics, anesthetics, and some antibioticsSteroids, narcotics, anesthetics, and some antibiotics
Can affect developing embryo or neonate if given Can affect developing embryo or neonate if given to pregnant motherto pregnant mother
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
BiotransformationBiotransformationProcess by which the drug is chemically Process by which the drug is chemically converted to a metaboliteconverted to a metabolite
Purpose is to "detoxify" a drug and render it less Purpose is to "detoxify" a drug and render it less activeactive
Liver is primary site of drug metabolismLiver is primary site of drug metabolism
If drug metabolism is delayed, drug accumulation If drug metabolism is delayed, drug accumulation and cumulative drug effects may occurand cumulative drug effects may occur
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
ExcretionExcretionElimination of toxic or inactive metabolitesElimination of toxic or inactive metabolites
Organs of excretionOrgans of excretionKidneysKidneysIntestineIntestineLungsLungsSweat and salivary glandsSweat and salivary glandsMammary glandsMammary glands
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Mosby, Inc. items and derived items © 2007, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
16
Excretion by KidneysExcretion by KidneysCan be excreted in Can be excreted in urine unchanged or as urine unchanged or as metabolite of its metabolite of its previous formprevious form
Renal excretionRenal excretionPassive glomerular Passive glomerular filtrationfiltrationPartial reabsorptionPartial reabsorptionActive tubular secretionActive tubular secretion
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
HemodialysisHemodialysisSubstances completely or almost completely Substances completely or almost completely excreted by the normal kidney can be excreted by the normal kidney can be removed by this artificial processremoved by this artificial process
Not effective for highly tissueNot effective for highly tissue-- or proteinor protein--bound drugs bound drugs
Limited benefit with rapidly acting toxinsLimited benefit with rapidly acting toxins
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Excretion by the IntestineExcretion by the IntestineDrugs eliminated by biliary excretionDrugs eliminated by biliary excretion
After liver metabolism, metabolites are carried in After liver metabolism, metabolites are carried in bile, passed into duodenum, and eliminated with bile, passed into duodenum, and eliminated with fecesfeces
Some drugs are reabsorbed by the bloodstream, Some drugs are reabsorbed by the bloodstream, returned to the liver, and later excreted by the returned to the liver, and later excreted by the kidneyskidneys
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Mosby, Inc. items and derived items © 2007, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
17
Excretion by the LungsExcretion by the Lungs
Drugs that can be excreted by the lungs includeDrugs that can be excreted by the lungs includeGeneral anestheticsGeneral anestheticsVolatile alcoholsVolatile alcoholsInhaled bronchodilatorsInhaled bronchodilators
Factors that can alter elimination via the lungs Factors that can alter elimination via the lungs areare
Rate and depth of respirationRate and depth of respirationCardiac outputCardiac output
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Secretion through Sweat Secretion through Sweat and Salivary Glandsand Salivary Glands
Sweat is unimportant means of drug excretionSweat is unimportant means of drug excretion
Drugs excreted in saliva are usually swallowed Drugs excreted in saliva are usually swallowed and eliminated in the same manner as other and eliminated in the same manner as other orally administered drugsorally administered drugs
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Excretion through Mammary GlandsExcretion through Mammary Glands
Many drugs or their metabolites cross the Many drugs or their metabolites cross the epithelium of the mammary glandsepithelium of the mammary glands
Are excreted in breast milkAre excreted in breast milk
Breast milk is acidic (pH 6.5)Breast milk is acidic (pH 6.5)
Nursing mothers are cautioned against Nursing mothers are cautioned against medication usemedication use
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Mosby, Inc. items and derived items © 2007, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
18
Factors that Influence Actions of DrugsFactors that Influence Actions of Drugs
AgeAge
Body massBody mass
GenderGender
EnvironmentEnvironment
Time of administrationTime of administration
Pathological statePathological state
Genetic factorsGenetic factors
Psychological factorsPsychological factors
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Pharmacokinetic Phase ofPharmacokinetic Phase ofDrug ActionDrug Action
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
PharmacodynamicsPharmacodynamicsStudy of how a drug acts on a living organismStudy of how a drug acts on a living organism
Pharmacologic response relative to the Pharmacologic response relative to the concentration of a drug at an active site in the concentration of a drug at an active site in the organismorganism
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Mosby, Inc. items and derived items © 2007, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
19
PharmacodynamicsPharmacodynamicsMost drugs produce effects by:Most drugs produce effects by:
DrugDrug--receptor interactionreceptor interaction•• AgonistsAgonists•• AntagonistsAntagonists•• AffinityAffinity•• EfficacyEfficacy•• Types of receptors Types of receptors
DrugDrug--enzyme interactionenzyme interactionNonspecific drug interactionNonspecific drug interaction
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
DrugDrug--Receptor InteractionReceptor Interaction
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
DrugDrug--Receptor InteractionReceptor InteractionAgonists Agonists
Drugs that bind to a receptor and cause a Drugs that bind to a receptor and cause a physiological responsephysiological response
AntagonistsAntagonistsDrugs that bind to a receptor and whose presence Drugs that bind to a receptor and whose presence prevents a physiological response or other drugs prevents a physiological response or other drugs from bindingfrom binding
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Mosby, Inc. items and derived items © 2007, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
20
Drug Response AssessmentDrug Response AssessmentAssess by observing the physiological Assess by observing the physiological parametersparameters
e.g., BP, paine.g., BP, pain
Effects of some drugs cannot be monitored Effects of some drugs cannot be monitored solely by the patient's responsesolely by the patient's response
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Plasma Level ProfilesPlasma Level ProfilesRelationship between plasma concentration Relationship between plasma concentration and level of therapeutic effectiveness over and level of therapeutic effectiveness over timetime
Depend on:Depend on:•• Rate of absorptionRate of absorption•• DistributionDistribution•• BiotransformationBiotransformation•• Excretion Excretion
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Plasma Level ProfilesPlasma Level ProfilesTherapeutic rangeTherapeutic range
Concentration (dose) that provides highest Concentration (dose) that provides highest probability of responseprobability of response
Least risk of toxicityLeast risk of toxicitySome patients fail to respond to therapeutic dosesSome patients fail to respond to therapeutic dosesOthers may develop toxicityOthers may develop toxicity
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Mosby, Inc. items and derived items © 2007, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
21
Plasma Level ProfilesPlasma Level Profiles
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Biological HalfBiological Half--LifeLifeTime needed to metabolize or eliminate half Time needed to metabolize or eliminate half of total amount of drug in bodyof total amount of drug in body
A drug is considered gone from the body after A drug is considered gone from the body after five halffive half--lives have passedlives have passed
Affected by renal and hepatic functionAffected by renal and hepatic function
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Therapeutic IndexTherapeutic IndexMeasures relative safety of a drugMeasures relative safety of a drug
Ratio between:Ratio between:Lethal dose 50 (LD 50)Lethal dose 50 (LD 50)
•• Dose of a drug lethal in 50% of laboratory animals testedDose of a drug lethal in 50% of laboratory animals testedEffectiveness dose (ED 50)Effectiveness dose (ED 50)
•• Dose that produces a therapeutic effect in 50% of a Dose that produces a therapeutic effect in 50% of a similar populationsimilar population
TI = LD 50/ED 50TI = LD 50/ED 50The closer the ratio to 1, the greater the danger in The closer the ratio to 1, the greater the danger in administering the drug to humansadministering the drug to humans
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Mosby, Inc. items and derived items © 2007, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
22
DrugDrug--Receptor InteractionReceptor InteractionMost drug actionsMost drug actions
Chemical interaction between drug and various Chemical interaction between drug and various receptors in bodyreceptors in bodyMost common form of drug action is the drugMost common form of drug action is the drug--receptor interactionreceptor interaction
Most drugs are thought to bind to drug Most drugs are thought to bind to drug receptors to produce their desired effectreceptors to produce their desired effect
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Drug InteractionsDrug InteractionsVariables influencing drug interaction:Variables influencing drug interaction:
Intestinal absorptionIntestinal absorptionCompetition for plasma protein bindingCompetition for plasma protein bindingDrug metabolism or biotransformationDrug metabolism or biotransformationAction at the receptor siteAction at the receptor siteRenal excretionRenal excretionAlteration of electrolyte balanceAlteration of electrolyte balance
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
DrugDrug--Drug InteractionsDrug InteractionsSome drugSome drug--drug interactions are dangerousdrug interactions are dangerous
Drugs associated with significant interactions:Drugs associated with significant interactions:Blood thinnersBlood thinnersTricyclic antidepressantsTricyclic antidepressantsMonoamine oxidase (MAO) inhibitorsMonoamine oxidase (MAO) inhibitorsAmphetaminesAmphetaminesDigitalis glycosidesDigitalis glycosidesDiureticsDiureticsAntihypertensivesAntihypertensives
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Mosby, Inc. items and derived items © 2007, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
23
Drug InteractionsDrug InteractionsOther factors influencing drug interactions:Other factors influencing drug interactions:
DrugDrug--induced malabsorption of foods and induced malabsorption of foods and nutrientsnutrientsFoodFood--induced malabsorption of drugsinduced malabsorption of drugsEnzyme alterations that affect the metabolism of Enzyme alterations that affect the metabolism of foods or drugsfoods or drugsAlcohol consumptionAlcohol consumptionCigarette smokingCigarette smokingFoodFood--initiated alteration of drug excretioninitiated alteration of drug excretion
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Drug StorageDrug StorageRefer to local protocolRefer to local protocol
Drug potency can be affected by:Drug potency can be affected by:TemperatureTemperatureLightLightMoistureMoistureShelf lifeShelf life
Controlled medications securityControlled medications security
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Paramedic ResponsibilitiesParamedic Responsibilities
Use correct medications and techniquesUse correct medications and techniquesObserve and document the effects of drugsObserve and document the effects of drugsKeep current on changes in pharmacology Keep current on changes in pharmacology trendstrendsMaintain professional relationships with Maintain professional relationships with health care teamhealth care team
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Mosby, Inc. items and derived items © 2007, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
24
Paramedic ResponsibilitiesParamedic Responsibilities
Understand pharmacodynamics of drugs Understand pharmacodynamics of drugs being administeredbeing administeredCarefully evaluate patients for drug Carefully evaluate patients for drug indications and contraindicationsindications and contraindicationsTake a thorough patient medication historyTake a thorough patient medication historyConsult with medical direction as neededConsult with medical direction as needed
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Components of a Drug ProfileComponents of a Drug Profile
Drug namesDrug namesClassificationClassificationIndicationsIndicationsPharmacokineticsPharmacokineticsSide/adverse effectsSide/adverse effects
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Components of a Drug ProfileComponents of a Drug Profile
DosagesDosagesRoutes of administrationRoutes of administrationContraindicationsContraindicationsSpecial considerationsSpecial considerationsStorage requirementsStorage requirements
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Mosby, Inc. items and derived items © 2007, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
25
Special ConsiderationsSpecial ConsiderationsPregnant patientsPregnant patients
Pediatric patientsPediatric patients
Geriatric patientsGeriatric patients
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Pregnancy Ratings for DrugsPregnancy Ratings for DrugsCategory ACategory A
Risk of fetal harm remoteRisk of fetal harm remoteCategory BCategory B
Inconclusive risk in first trimester, no risk in later trimesterInconclusive risk in first trimester, no risk in later trimesterssCategory CCategory C
Give only if potential benefit outweighs risk to fetusGive only if potential benefit outweighs risk to fetusCategory DCategory D
Evidence of fetal risk; may be acceptable if lifeEvidence of fetal risk; may be acceptable if life--threatening threatening situationsituation
Category XCategory XRisk outweighs any benefitRisk outweighs any benefit
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
PediatricsPediatricsEffects unpredictable in infantsEffects unpredictable in infants
Drug doses weight relatedDrug doses weight related
Higher doses of waterHigher doses of water--soluble drugs may be neededsoluble drugs may be needed
Less effective bloodLess effective blood--brain barrier in infantsbrain barrier in infants
Slow drug clearance, excretionSlow drug clearance, excretion
Longer halfLonger half--lifelife
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Mosby, Inc. items and derived items © 2007, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
26
Elderly PatientElderly PatientCauses of noncompliance and medication Causes of noncompliance and medication errors:errors:
Expense Expense Forgetfulness or confusionForgetfulness or confusionSymptoms disappearSymptoms disappearErrors in taking medicationsErrors in taking medicationsNoncompliance may be deliberateNoncompliance may be deliberate
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Drugs that Affect theDrugs that Affect theNervous SystemNervous System
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Autonomic Nervous SystemAutonomic Nervous SystemEffects of many drugs depend on:Effects of many drugs depend on:
Which branch of ANS they act onWhich branch of ANS they act onWhether the ANS branch is stimulated or inhibited Whether the ANS branch is stimulated or inhibited by drug therapyby drug therapy
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Mosby, Inc. items and derived items © 2007, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
27
Autonomic Nervous SystemAutonomic Nervous SystemCNSCNS
BrainBrainSpinal cordSpinal cord
PNSPNSCranial and spinal nerves and their branchesCranial and spinal nerves and their branchesConnects all parts of body to CNSConnects all parts of body to CNS
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Types of Nerve FibersTypes of Nerve FibersVisceral afferent (sensory)Visceral afferent (sensory)
Convey impulses from internal organs to CNSConvey impulses from internal organs to CNS
Visceral efferent (motor)Visceral efferent (motor)Convey impulses from CNS to internal organs, glands, and Convey impulses from CNS to internal organs, glands, and smooth and cardiac musclesmooth and cardiac muscle
Somatic afferent (sensory)Somatic afferent (sensory)Convey impulses from head, body wall, and extremities to Convey impulses from head, body wall, and extremities to CNSCNS
Somatic efferent (motor)Somatic efferent (motor)Convey impulses from CNS to striated musclesConvey impulses from CNS to striated muscles
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Autonomic Nervous SystemAutonomic Nervous SystemPeripheral nervous system provides a double Peripheral nervous system provides a double set of nerve fibers:set of nerve fibers:
Sympathetic (adrenergic)Sympathetic (adrenergic)•• Exit from thoracic and lumbar regions Exit from thoracic and lumbar regions
Parasympathetic (cholinergic)Parasympathetic (cholinergic)•• Exit from cranial and sacral portions Exit from cranial and sacral portions
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Mosby, Inc. items and derived items © 2007, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
28
Autonomic Nervous SystemAutonomic Nervous SystemSympathetic nerve stimulationSympathetic nerve stimulation
Excitatory effects in some organs Excitatory effects in some organs Inhibits effects in othersInhibits effects in others
Parasympathetic stimulationParasympathetic stimulationExcitation in some organsExcitation in some organsInhibition in othersInhibition in others
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Autonomic Nervous SystemAutonomic Nervous SystemBoth systems function continuouslyBoth systems function continuously
Occasionally react in reciprocal fashionOccasionally react in reciprocal fashion
Most organs are dominantly controlled by one Most organs are dominantly controlled by one systemsystem
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Overview of Nervous SystemOverview of Nervous System
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Mosby, Inc. items and derived items © 2007, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
29
PrePre-- and Postganglionic Neuronsand Postganglionic Neurons
A twoA two--neuron chain exists in a series neuron chain exists in a series between the CNS and effector organsbetween the CNS and effector organs
Preganglionic neuron located in the CNSPreganglionic neuron located in the CNS•• Passes between CNS and gangliaPasses between CNS and ganglia
Postganglionic neuron located in the peripheryPostganglionic neuron located in the periphery•• Passes between ganglia and effector organPasses between ganglia and effector organ
SynapseSynapseJunction between two neuronsJunction between two neurons
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Autonomic Conduction PathwaysAutonomic Conduction Pathways
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Acetylcholine (ACh)Acetylcholine (ACh)NeurotransmitterNeurotransmitter
At junction between preganglionic fiber and At junction between preganglionic fiber and synapsesynapseAt junction between postganglionic fiber and At junction between postganglionic fiber and effector celleffector cellFibers that release ACh are known as Fibers that release ACh are known as cholinergic cholinergic fibersfibers
•• All preganglionic fibers of autonomic divisionAll preganglionic fibers of autonomic division•• All postganglionic fibers of parasympathetic divisionAll postganglionic fibers of parasympathetic division
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Mosby, Inc. items and derived items © 2007, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
30
NorepinephrineNorepinephrineNeurotransmitter between sympathetic Neurotransmitter between sympathetic postganglionic fiber and effector cellpostganglionic fiber and effector cell
Adrenergic fibersAdrenergic fibersRelease norepinephrine Release norepinephrine Most postganglionic neurons of the sympathetic Most postganglionic neurons of the sympathetic division are adrenergicdivision are adrenergic
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Nerve Impulse TransmissionNerve Impulse TransmissionAcetylcholine combines with cholinergic Acetylcholine combines with cholinergic receptorsreceptors
NicotinicNicotinic•• Excitatory responseExcitatory response
MuscarinicMuscarinic•• Excites or inhibitsExcites or inhibits
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Nerve Impulse TransmissionNerve Impulse TransmissionNorepinephrine combines with alpha and Norepinephrine combines with alpha and beta receptors in effector organsbeta receptors in effector organs
Binds to and activates both types of receptor Binds to and activates both types of receptor moleculesmolecules
•• More affinity for alpha receptorsMore affinity for alpha receptors
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Mosby, Inc. items and derived items © 2007, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
31
Nerve Impulse TransmissionNerve Impulse TransmissionEpinephrine is an adrenergic substance:Epinephrine is an adrenergic substance:
Produced by adrenal medullaProduced by adrenal medullaNearly equal affinity for both receptorsNearly equal affinity for both receptorsIn tissues containing alphaIn tissues containing alpha-- and betaand beta--receptor receptor cells, one type is more abundantcells, one type is more abundantHas a dominating effectHas a dominating effect
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Nerve Impulse TransmissionNerve Impulse Transmission
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Drugs that Affect the ANSDrugs that Affect the ANS
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Mosby, Inc. items and derived items © 2007, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
32
ClassificationsClassificationsCholinergic (parasympathomimetic)Cholinergic (parasympathomimetic)
Cholinergic blocking (parasympatholytic)Cholinergic blocking (parasympatholytic)
Adrenergic (sympathomimetic)Adrenergic (sympathomimetic)
Adrenergic blocking (sympatholytic)Adrenergic blocking (sympatholytic)
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Narcotic Analgesics and AntagonistsNarcotic Analgesics and Antagonists
Narcotic analgesics relieve painNarcotic analgesics relieve pain
Narcotic antagonists reverse the narcotic Narcotic antagonists reverse the narcotic effects of some narcotic analgesicseffects of some narcotic analgesics
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Pain ComponentsPain ComponentsSensation of painSensation of pain
•• Involves the nerve pathways and the brainInvolves the nerve pathways and the brain
Emotional response to painEmotional response to pain•• Anxiety levelAnxiety level•• Previous pain experience Previous pain experience •• AgeAge•• GenderGender•• CultureCulture
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Mosby, Inc. items and derived items © 2007, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
33
NarcoticsNarcoticsContain or abstracted from opiumContain or abstracted from opium
Morphine: Chief alkaloid of opiumMorphine: Chief alkaloid of opium
Bind with opioid receptors in brain and other Bind with opioid receptors in brain and other body organsbody organs
Alters pain perception and emotional response to Alters pain perception and emotional response to painpain
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
NarcoticsNarcoticsUndesirable effectsUndesirable effects
Nausea and vomitingNausea and vomitingConstipationConstipationUrinary retentionUrinary retentionCough reflex suppressionCough reflex suppressionOrthostatic hypotensionOrthostatic hypotensionCNS depressionCNS depression
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Opioid AnalgesicsOpioid AnalgesicsMorphine (morphine sulfate)Morphine (morphine sulfate)Codeine (methylmorphine)Codeine (methylmorphine)Hydromorphone (Dilaudid, DilaudidHydromorphone (Dilaudid, Dilaudid--HP)HP)Meperidine (Demerol)Meperidine (Demerol)Methadone (Dolophine, Methadose)Methadone (Dolophine, Methadose)Oxycodone (Percodan, Tylox, Percocet)Oxycodone (Percodan, Tylox, Percocet)Hydrocodone (Lortab)Hydrocodone (Lortab)Propoxyphene (Darvon, Dolene)Propoxyphene (Darvon, Dolene)
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Mosby, Inc. items and derived items © 2007, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
34
Opioid AntagonistsOpioid Antagonists““BlockBlock”” opioid analgesics opioid analgesics
Displace analgesics from receptor sitesDisplace analgesics from receptor sites
Examples:Examples:Naloxone (Narcan)Naloxone (Narcan)Naltrexone (Trexan)Naltrexone (Trexan)Nalmefene (Revex)Nalmefene (Revex)
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Opioid AgonistOpioid Agonist--AntagonistsAntagonistsAnalgesic and antagonist effectsAnalgesic and antagonist effects
Pharmacokinetic and adverse effects similar to Pharmacokinetic and adverse effects similar to morphinemorphine
Lower dependency risk than opioidsLower dependency risk than opioidsLess severe withdrawal symptomsLess severe withdrawal symptomsMay cause withdrawal symptoms in addictsMay cause withdrawal symptoms in addicts
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Nonnarcotic AnalgesicsNonnarcotic AnalgesicsPeripheral mechanism Peripheral mechanism
Interferes with local mediators released when Interferes with local mediators released when tissue is damagedtissue is damaged
Mediators stimulate nerve endingsMediators stimulate nerve endingsCause pain Cause pain
Nonnarcotic analgesics decrease nerve ending Nonnarcotic analgesics decrease nerve ending stimulationstimulation
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Mosby, Inc. items and derived items © 2007, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
35
AnestheticsAnestheticsCNS depressants CNS depressants
Reversible action on nervous tissueReversible action on nervous tissue
Major categories of anesthesia:Major categories of anesthesia:GeneralGeneralRegionalRegionalLocalLocal
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Antianxiety Agents and AlcoholAntianxiety Agents and Alcohol
Antianxiety agentsAntianxiety agentsReduce feelings of apprehensionReduce feelings of apprehensionNervousnessNervousnessWorryWorryFearfulnessFearfulness
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
SedativeSedative--Hypnotic AgentsHypnotic AgentsDepress CNSDepress CNS
Calming effectCalming effect
Sedatives and hypnotics differ by degree of Sedatives and hypnotics differ by degree of CNS depressionCNS depression
Agent may be sedative Agent may be sedative andand hypnotichypnoticDepends on dose usedDepends on dose used
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Mosby, Inc. items and derived items © 2007, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
36
AlcoholAlcoholCNS depressantCNS depressant
Can produce sedation, sleep, and anesthesiaCan produce sedation, sleep, and anesthesia
Enhances sedativeEnhances sedative--hypnotic effects of other hypnotic effects of other drugsdrugs
Blood alcohol measured (mg/dL)Blood alcohol measured (mg/dL)Behavioral effects based on blood alcohol levelsBehavioral effects based on blood alcohol levels
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
BenzodiazepinesBenzodiazepinesBind to receptors in cerebral cortex and limbic Bind to receptors in cerebral cortex and limbic system system
ActionsActionsAnxiety reducingAnxiety reducingSedativeSedative--hypnotichypnoticMuscle relaxingMuscle relaxingAnticonvulsantAnticonvulsant
Schedule IV drugs Schedule IV drugs
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
BenzodiazepinesBenzodiazepinesCommonly prescribed benzodiazepinesCommonly prescribed benzodiazepines
Alprazolam (Xanax)Alprazolam (Xanax)Chlordiazepoxide (Librium)Chlordiazepoxide (Librium)Clorazepate (Tranxene)Clorazepate (Tranxene)Diazepam (Valium)Diazepam (Valium)Flurazepam (Dalmane)Flurazepam (Dalmane)Prazepam (Centrax)Prazepam (Centrax)Midazolam (Versed)Midazolam (Versed)Lorazepam (Ativan)Lorazepam (Ativan)Triazolam (Halcion)Triazolam (Halcion)
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Mosby, Inc. items and derived items © 2007, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
37
BarbituratesBarbituratesDuration of action Duration of action
UltraUltra--short actingshort actingShort actingShort actingIntermediate actingIntermediate actingLong actingLong acting
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Miscellaneous Miscellaneous SedativeSedative--Hypnotic DrugsHypnotic Drugs
Not benzodiazepines or barbituratesNot benzodiazepines or barbiturates
More like barbiturates than benzodiazepinesMore like barbiturates than benzodiazepines
ExamplesExamplesChloral hydrate (Noctec)Chloral hydrate (Noctec)Ethchlorvynol (Placidyl)Ethchlorvynol (Placidyl)Meprobamate (Equanil, Meprospan)Meprobamate (Equanil, Meprospan)
Some antihistamines have sedative effectsSome antihistamines have sedative effectsHydroxyzine hydrochloride (Vistaril, Atarax)Hydroxyzine hydrochloride (Vistaril, Atarax)
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
AnticonvulsantsAnticonvulsantsTreat seizure disordersTreat seizure disorders
Mode of action not understoodMode of action not understood
Choice of drug depends on:Choice of drug depends on:Type of seizure disorder Type of seizure disorder Patient's drug tolerance Patient's drug tolerance Medication noncompliance commonMedication noncompliance common
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Mosby, Inc. items and derived items © 2007, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
38
CNS StimulantsCNS StimulantsClassified by site of actionClassified by site of action
CerebrumCerebrumMedulla and brainstemMedulla and brainstemHypothalamic limbic regionsHypothalamic limbic regions
Common CNS stimulant drugsCommon CNS stimulant drugsAnorexiantsAnorexiantsAmphetaminesAmphetamines
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Psychotherapeutic DrugsPsychotherapeutic DrugsPsychotherapeutic drugs includePsychotherapeutic drugs include
Antipsychotic agentsAntipsychotic agentsAntidepressantsAntidepressantsLithiumLithium
Treat psychoses and affective disordersTreat psychoses and affective disordersSchizophrenia, depression, and maniaSchizophrenia, depression, and mania
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Psychotherapeutic DrugsPsychotherapeutic Drugs
Neurotransmitters in Neurotransmitters in CNS affecting emotion:CNS affecting emotion:
AcetylcholineAcetylcholineNorepinephrineNorepinephrineDopamineDopamineSerotoninSerotoninMonoamine oxidaseMonoamine oxidase
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Mosby, Inc. items and derived items © 2007, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
39
CNS and EmotionsCNS and EmotionsAlterations in neurotransmitter levels Alterations in neurotransmitter levels associated with changes in mood and associated with changes in mood and behaviorbehavior
Drug therapy alleviates symptoms Drug therapy alleviates symptoms Temporarily modifies unwanted behaviorTemporarily modifies unwanted behavior
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Antipsychotic AgentsAntipsychotic AgentsSchizophrenia (primary use)Schizophrenia (primary use)
Tourette syndromeTourette syndrome
Senile dementia associated with Alzheimer Senile dementia associated with Alzheimer diseasedisease
Antipsychotic (neuroleptic) drugs block CNS Antipsychotic (neuroleptic) drugs block CNS dopamine receptorsdopamine receptors
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Antipsychotic AgentsAntipsychotic AgentsClassificationsClassifications
Phenothiazine derivativesPhenothiazine derivativesButyrophenone derivativesButyrophenone derivativesDihydroindolone derivativesDihydroindolone derivativesDibenzoxapine derivativesDibenzoxapine derivativesThienbenzodiazepine derivativesThienbenzodiazepine derivativesAtypical agentsAtypical agents
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Mosby, Inc. items and derived items © 2007, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
40
AntidepressantsAntidepressantsTreatment of affective disorders (mood Treatment of affective disorders (mood disturbances)disturbances)
DepressionDepressionManiaManiaElationElation
Tricyclic antidepressants and MAO inhibitors Tricyclic antidepressants and MAO inhibitors are prescribed for depressionare prescribed for depression
Lithium is preferred treatment for maniaLithium is preferred treatment for mania
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
AntidepressantsAntidepressantsNewer classes of antidepressants (secondNewer classes of antidepressants (second--generation drugs) have been developedgeneration drugs) have been developed
ExamplesExamplesBupropion (Wellbutrin)Bupropion (Wellbutrin)Fluoxetine (Prozac)Fluoxetine (Prozac)Trazodone (Desyrel)Trazodone (Desyrel)Sertraline (Zoloft)Sertraline (Zoloft)Paroxetine (Paxil)Paroxetine (Paxil)
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Tricyclic AntidepressantsTricyclic AntidepressantsIncrease levels (block reuptake) of Increase levels (block reuptake) of norepinephrine and serotoninnorepinephrine and serotonin
ExamplesExamplesImipramine (Tofranil) Imipramine (Tofranil) Amitriptyline (Elavil)Amitriptyline (Elavil)
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Mosby, Inc. items and derived items © 2007, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
41
MAO InhibitorsMAO InhibitorsCentralCentral--acting monoamines, especially acting monoamines, especially norepinephrine and serotonin are thought to norepinephrine and serotonin are thought to cause depression and maniacause depression and mania
Monoamine oxidase is responsible for Monoamine oxidase is responsible for metabolizing norepinephrine within nervemetabolizing norepinephrine within nerveMAO inhibitors block this enzyme, leading to MAO inhibitors block this enzyme, leading to increased norepinephrine levelsincreased norepinephrine levels
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
LithiumLithiumAlters sodium transport in nerve and muscle Alters sodium transport in nerve and muscle cellscells
Affects norepinephrine and serotoninAffects norepinephrine and serotonin
Antimanic effects are thought to result from:Antimanic effects are thought to result from:Increased norepinephrine uptakeIncreased norepinephrine uptakeIncreased serotonin receptor sensitivityIncreased serotonin receptor sensitivity
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Drugs for Specific Drugs for Specific CNSCNS--Peripheral DysfunctionPeripheral Dysfunction
Parkinson diseaseParkinson diseaseMuscle rigidityMuscle rigidityTremorsTremorsSuspected cause: Low dopamine levelsSuspected cause: Low dopamine levels
Huntington diseaseHuntington diseaseProgressive dementiaProgressive dementiaInvoluntary muscle twitchingInvoluntary muscle twitchingDopamine, acetylcholine imbalanceDopamine, acetylcholine imbalance
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Mosby, Inc. items and derived items © 2007, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
42
Drugs with Drugs with Central Anticholinergic ActivityCentral Anticholinergic Activity
Inhibit or block acetylcholineInhibit or block acetylcholineAnticholinergicAnticholinergic
Restore brainRestore brain’’s dopamines dopamine--acetylcholine acetylcholine balance balance
ExamplesExamplesBenztropine (tablets and injections)Benztropine (tablets and injections)Ethopropazine hydrochlorideEthopropazine hydrochloride
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Drugs Affecting Brain DopamineDrugs Affecting Brain Dopamine
Three classificationsThree classificationsThose that release dopamineThose that release dopamineThose that increase brain levels of dopamineThose that increase brain levels of dopamineDopaminergic agonistsDopaminergic agonists
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Skeletal Muscle RelaxantsSkeletal Muscle RelaxantsCentral actingCentral acting
Baclofen (lioresal)Baclofen (lioresal)Cyclobenzaprine (flexeril)Cyclobenzaprine (flexeril)Diazepam (valium)Diazepam (valium)
Direct actingDirect actingDantrolene (Dantrium)Dantrolene (Dantrium)
Neuromuscular blockersNeuromuscular blockersCan cause paralysisCan cause paralysisPancuronium (Pavulon), vecuronium (Norcuron)Pancuronium (Pavulon), vecuronium (Norcuron)Succinylcholine (Anectine)Succinylcholine (Anectine)
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Mosby, Inc. items and derived items © 2007, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
43
Drugs Affecting the ANSDrugs Affecting the ANSAutonomic drugsAutonomic drugs
Mimic or block effects of sympathetic and Mimic or block effects of sympathetic and parasympathetic divisions of autonomic parasympathetic divisions of autonomic nervous systemnervous system
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Autonomic DrugsAutonomic DrugsCholinergic drugsCholinergic drugs
ParasympathomimeticParasympathomimeticMimic parasympathetic nervous systemMimic parasympathetic nervous system
CholinergicCholinergic--blocking drugsblocking drugsParasympatholyticParasympatholyticBlock parasympathetic nervous systemBlock parasympathetic nervous system
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Autonomic DrugsAutonomic DrugsAdrenergic drugsAdrenergic drugs
SympathomimeticSympathomimeticMimic sympathetic nervous system (adrenal Mimic sympathetic nervous system (adrenal medulla)medulla)
AdrenergicAdrenergic--blocking drugsblocking drugsSympatholyticSympatholyticBlock actions of sympathetic nervous system Block actions of sympathetic nervous system (adrenal medulla)(adrenal medulla)
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Mosby, Inc. items and derived items © 2007, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
44
ReceptorsReceptorsCatecholamines act on alpha and beta receptorsCatecholamines act on alpha and beta receptors
Alpha 1Alpha 1Alpha 2Alpha 2Beta 1Beta 1Beta 2Beta 2
NorepinephrineNorepinephrineActs mainly on alpha receptorsActs mainly on alpha receptors
EpinephrineEpinephrineActs on alpha and beta receptorsActs on alpha and beta receptors
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Alpha and Beta ActivitiesAlpha and Beta ActivitiesAlpha activitiesAlpha activities
VasoconstrictionVasoconstriction•• Arterioles in the skin and splanchnic areaArterioles in the skin and splanchnic area•• Pupil dilationPupil dilation
Relaxation of the gutRelaxation of the gut
Beta activitiesBeta activitiesCardiac acceleration and increased contractilityCardiac acceleration and increased contractilityVasodilation of skeletal muscle arteriolesVasodilation of skeletal muscle arteriolesBronchial relaxationBronchial relaxationUterine relaxationUterine relaxation
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
AlphaAlpha--Blocking DrugsBlocking DrugsBlock the vasoconstricting effect of Block the vasoconstricting effect of catecholaminescatecholamines
Used in certain cases of hypertensionUsed in certain cases of hypertensionPrevent necrosis after norepinephrine (Levophed) Prevent necrosis after norepinephrine (Levophed) or dopamine (Intropin) extravasation into tissuesor dopamine (Intropin) extravasation into tissuesLimited use in prehospital settingLimited use in prehospital setting
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Mosby, Inc. items and derived items © 2007, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
45
BetaBeta--Blocking AgentsBlocking AgentsBlock beta receptorsBlock beta receptors
Selective beta 1 blockersSelective beta 1 blockersMetoprolol, atenololMetoprolol, atenololTreatment of hypertension, anginaTreatment of hypertension, angina
Nonselective beta blockersNonselective beta blockersNadolol, propranolol, labetalolNadolol, propranolol, labetalolAntianginal, antihypertensivesAntianginal, antihypertensives
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Cardiac Drug TerminologyCardiac Drug TerminologyChronotropic drugsChronotropic drugs
Affect heart rateAffect heart rate
Dromotropic drugsDromotropic drugsAffect conduction velocity through the conducting Affect conduction velocity through the conducting tissues of the hearttissues of the heart
Inotropic drugsInotropic drugsAffect force of contractionAffect force of contraction
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Cardiac GlycosidesCardiac GlycosidesPositive inotropic effectPositive inotropic effect
Increase contractilityIncrease contractility
Negative chronotropic effectNegative chronotropic effectSlow heart rateSlow heart rate
Negative dromotropic effectNegative dromotropic effectSlow conduction velocitySlow conduction velocity
Digoxin (Lanoxin)Digoxin (Lanoxin)
Small therapeutic indexSmall therapeutic index
Side effects commonSide effects common
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Mosby, Inc. items and derived items © 2007, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
46
AntidysrhythmicsAntidysrhythmicsTreat and prevent disorders of cardiac rhythmTreat and prevent disorders of cardiac rhythm
Work by:Work by:Direct action on the cardiac cell membrane Direct action on the cardiac cell membrane (lidocaine)(lidocaine)Indirect action that affects the cell (propranolol)Indirect action that affects the cell (propranolol)BothBoth
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
AntidysrhythmicsAntidysrhythmics——ClassificationsClassifications
Based on mode of action on cardiac muscleBased on mode of action on cardiac muscle
Drugs that belong to the same class do not Drugs that belong to the same class do not produce identical actionsproduce identical actions
All antidysrhythmics can suppress All antidysrhythmics can suppress automaticityautomaticity
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Class I Sodium Channel BlockersClass I Sodium Channel BlockersClass IClass I--AA
Decrease conduction velocityDecrease conduction velocityProlong electrical potential of cardiac tissueProlong electrical potential of cardiac tissueProcainamide (Pronestyl)Procainamide (Pronestyl)
Class IClass I--BBDecrease or have no effect on conduction velocityDecrease or have no effect on conduction velocityLidocaine (Xylocaine)Lidocaine (Xylocaine)
Class IClass I--CCProfoundly slow conductionProfoundly slow conductionControl lifeControl life--threatening ventricular dysrhythmiasthreatening ventricular dysrhythmiasFlecainide (Tambocor)Flecainide (Tambocor)
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Mosby, Inc. items and derived items © 2007, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
47
Class IIClass IIBetaBeta--blocking agents blocking agents
Reduce adrenergic stimulation of the heartReduce adrenergic stimulation of the heartNegative chronotropeNegative chronotrope
•• Propranolol (Inderal)Propranolol (Inderal)
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Class IIIClass IIIPotassium channel blockersPotassium channel blockers
Increase contractilityIncrease contractilityDo not suppress automaticity Do not suppress automaticity Have no effect on conduction velocityHave no effect on conduction velocity
Terminate dysrhythmias that result from Terminate dysrhythmias that result from reentry of blocked impulsesreentry of blocked impulses
Amiodarone (Cordarone)Amiodarone (Cordarone)
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Class IVClass IVCalcium channel blockersCalcium channel blockers
Block inflow of calcium through cell membranes of Block inflow of calcium through cell membranes of cardiac and smooth muscle cellscardiac and smooth muscle cells
•• Depresses the myocardial and smooth muscle Depresses the myocardial and smooth muscle contractioncontraction
•• Decreases automaticity and in some cases decreases Decreases automaticity and in some cases decreases conduction velocityconduction velocity
Diltiazem (Cardizem)Diltiazem (Cardizem)
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Mosby, Inc. items and derived items © 2007, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
48
AntihypertensivesAntihypertensivesDiureticsDiuretics
Sympathetic blocking agents (sympatholytic drugs)Sympathetic blocking agents (sympatholytic drugs)
VasodilatorsVasodilators
AngiotensinAngiotensin--converting enzyme (ACE) inhibitorsconverting enzyme (ACE) inhibitors
Calcium channel blockersCalcium channel blockers
Angiotensin II receptor antagonistsAngiotensin II receptor antagonists
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
DiureticsDiureticsRenal excretion of excess salt and water Renal excretion of excess salt and water
Thiazide diureticsThiazide diureticsModerately effective in lowering blood pressureModerately effective in lowering blood pressureHydrochlorothiazide (HCTZ)Hydrochlorothiazide (HCTZ)
Loop diureticsLoop diureticsShortShort--acting agents that inhibit sodium and chloride reabsorption in acting agents that inhibit sodium and chloride reabsorption in loop of Henleloop of HenleFurosemide (Lasix)Furosemide (Lasix)
PotassiumPotassium--sparing diureticssparing diureticsLess potassium loss than other diureticsLess potassium loss than other diureticsSpironolactone (Aldactone)Spironolactone (Aldactone)
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Sympathetic Blocking AgentsSympathetic Blocking AgentsBetaBeta--blocking agents and adrenergicblocking agents and adrenergic--inhibiting agentsinhibiting agents
BetaBeta--blocking agentsblocking agentsTreatment of suspected myocardial infarction, Treatment of suspected myocardial infarction,
highhigh--risk unstable angina, and hypertensionrisk unstable angina, and hypertension•• Atenolol (Tenormin), metoprolol (Lopressor)Atenolol (Tenormin), metoprolol (Lopressor)•• Labetalol (Normodyne, trandate), nadolol (Corgard)Labetalol (Normodyne, trandate), nadolol (Corgard)
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Mosby, Inc. items and derived items © 2007, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
49
Adrenergic Inhibiting AgentsAdrenergic Inhibiting AgentsCentrally acting adrenergic inhibitorsCentrally acting adrenergic inhibitors
Clonidine hydrochloride (Catapres)Clonidine hydrochloride (Catapres)
Peripheral adrenergic inhibitorsPeripheral adrenergic inhibitorsDoxazosin (Cardura)Doxazosin (Cardura)
Mechanism by which many of these agents Mechanism by which many of these agents work is unknownwork is unknown
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Vasodilator DrugsVasodilator DrugsAct directly on the smooth muscle walls of Act directly on the smooth muscle walls of arterioles, veins, or botharterioles, veins, or both
Lower peripheral resistance and blood Lower peripheral resistance and blood pressurepressure
Arteriolar dilator drugsArteriolar dilator drugs•• Hydralazine (Apresoline)Hydralazine (Apresoline)
Arteriolar and venous dilator drugsArteriolar and venous dilator drugs•• Nitroglycerin sublingual tablet (Nitrostat)Nitroglycerin sublingual tablet (Nitrostat)
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
AngiotensinAngiotensin--Converting Enzyme (ACE) Converting Enzyme (ACE) InhibitorsInhibitors
Angiotensin II is a powerful vasoconstrictor:Angiotensin II is a powerful vasoconstrictor:Raises blood pressureRaises blood pressureCauses the release of aldosteroneCauses the release of aldosterone
•• Contributes to sodium and water retentionContributes to sodium and water retentionInhibits conversion of angiotensin I to angiotensin Inhibits conversion of angiotensin I to angiotensin II (brought about through ACE)II (brought about through ACE)ReninRenin--angiotensinangiotensin--aldosterone system is aldosterone system is suppressedsuppressedBlood pressure is loweredBlood pressure is lowered
•• Captopril (Capoten)Captopril (Capoten)
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Mosby, Inc. items and derived items © 2007, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
50
Calcium Channel BlockersCalcium Channel BlockersInhibit contractility of vascular smooth muscleInhibit contractility of vascular smooth muscle
Reduce peripheral vascular resistance Reduce peripheral vascular resistance
Dilate coronary vessels Dilate coronary vessels Verapamil (Isoptin)Verapamil (Isoptin)Diltiazem (Cardizem)Diltiazem (Cardizem)
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Angiotensin II Receptor AntagonistsAngiotensin II Receptor Antagonists
Selectively inhibit angiotensin II receptorsSelectively inhibit angiotensin II receptors
Lower systolic and diastolic BPLower systolic and diastolic BPCandesartan (Atacand)Candesartan (Atacand)Irbesartan (Avapro)Irbesartan (Avapro)Losartan (Cozaar, Hyzaar)Losartan (Cozaar, Hyzaar)
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Monoamine Oxidase (MAO) InhibitorsMonoamine Oxidase (MAO) InhibitorsBlock release of norepinephrine at the sympathetic Block release of norepinephrine at the sympathetic junctionjunction
Interfere with vasoconstrictionInterfere with vasoconstriction
Reduce peripheral vascular resistanceReduce peripheral vascular resistance
Decrease blood pressureDecrease blood pressure
Not widely used to treat hypertensionNot widely used to treat hypertension
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Mosby, Inc. items and derived items © 2007, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
51
Antihemorrheological AgentsAntihemorrheological AgentsUsed to treat peripheral vascular disorders Used to treat peripheral vascular disorders caused by pathological or physiological caused by pathological or physiological obstruction obstruction
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Antihemophilic AgentsAntihemophilic AgentsHemophiliaHemophilia
Hemophilia A (classic hemophilia) is caused by a Hemophilia A (classic hemophilia) is caused by a deficiency of factor VIIIdeficiency of factor VIIIHemophilia B (the Hemophilia B (the ““Christmas diseaseChristmas disease””) results ) results from a deficiency in factor IX complexfrom a deficiency in factor IX complexReplacement therapy of the missing clotting factor Replacement therapy of the missing clotting factor can be effective in the management of hemophiliacan be effective in the management of hemophilia
•• Factor VIII (Factorate)Factor VIII (Factorate)•• Factor IX (Konyne)Factor IX (Konyne)•• Antiinhibitor coagulant complex (Autoplex)Antiinhibitor coagulant complex (Autoplex)
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Drugs that Affect the BloodDrugs that Affect the BloodDrugs that affect blood coagulation may be Drugs that affect blood coagulation may be classified as:classified as:
Antiplatelet agentsAntiplatelet agentsAnticoagulant agentsAnticoagulant agentsFibrinolytic agentsFibrinolytic agents
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Mosby, Inc. items and derived items © 2007, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
52
Antiplatelet AgentsAntiplatelet AgentsInterfere with platelet aggregationInterfere with platelet aggregation
Prevention of clots, MI, strokePrevention of clots, MI, stroke
Treatment of valvular disease, shuntsTreatment of valvular disease, shunts
Include:Include:Aspirin Aspirin Dipyridamole (Persantin)Dipyridamole (Persantin)Abciximab (ReoPro)Abciximab (ReoPro)
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
AnticoagulantsAnticoagulantsUsed to prevent intravascular thrombosisUsed to prevent intravascular thrombosis
Decreases blood coagulabilityDecreases blood coagulability
ExamplesExamplesHeparin (Liquaemin)Heparin (Liquaemin)Coumadin (Warfarin)Coumadin (Warfarin)
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Fibrinolytic AgentsFibrinolytic AgentsUsed to dissolve clots after formationUsed to dissolve clots after formation
Used for some acute myocardial infarctsUsed for some acute myocardial infarcts
Used in some stroke patientsUsed in some stroke patients
ExamplesExamplesStreptokinaseStreptokinaseTissue plasminogen activator (tTissue plasminogen activator (t--PA)PA)Reteplase (Retavase)Reteplase (Retavase)Alteplase (Activase)Alteplase (Activase)Tenecteplase (TNKase)Tenecteplase (TNKase)
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Mosby, Inc. items and derived items © 2007, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
53
Hemostatic AgentsHemostatic AgentsHasten clot formation to reduce bleedingHasten clot formation to reduce bleeding
Systemic hemostatic agents Systemic hemostatic agents •• Control rapid blood loss after surgery by inhibiting Control rapid blood loss after surgery by inhibiting
fibrinolysisfibrinolysis
Topical hemostatic agents Topical hemostatic agents •• Control capillary bleeding during surgical and dental Control capillary bleeding during surgical and dental
proceduresprocedures
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Blood and Blood ComponentsBlood and Blood ComponentsReplacement therapiesReplacement therapies
Whole blood (rarely used)Whole blood (rarely used)Packed red blood cellsPacked red blood cellsFreshFresh--frozen plasmafrozen plasmaPlasma expanders (Dextran)Plasma expanders (Dextran)PlateletsPlateletsCoagulation factorsCoagulation factorsFibrinogenFibrinogenAlbuminAlbuminGamma globulinsGamma globulins
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Antihyperlipidemic DrugsAntihyperlipidemic DrugsHyperlipidemia: Excess Hyperlipidemia: Excess lipids in plasmalipids in plasma
Used in conjunction Used in conjunction with diet and exercise to with diet and exercise to control serum lipid control serum lipid levelslevels
ExamplesExamplesAtorvastatin (Lipitor)Atorvastatin (Lipitor)Cholestyramine Cholestyramine (Questran)(Questran)Niacin (Nicobid)Niacin (Nicobid)Pravastatin (Pravachol) Pravastatin (Pravachol) Lovastatin (Mevacor)Lovastatin (Mevacor)Simvastatin (Zocor)Simvastatin (Zocor)
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Mosby, Inc. items and derived items © 2007, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
54
BronchodilatorsBronchodilatorsPrimary treatment for obstructive pulmonary Primary treatment for obstructive pulmonary diseasedisease
Asthma, chronic bronchitis, and emphysemaAsthma, chronic bronchitis, and emphysema
Classified as:Classified as:Sympathomimetic drugsSympathomimetic drugsXanthine derivativesXanthine derivatives
Many agents are administered by inhalation Many agents are administered by inhalation via a nebulizer or pressure cartridgevia a nebulizer or pressure cartridge
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Sympathomimetic DrugsSympathomimetic DrugsNonselective adrenergic drugsNonselective adrenergic drugs
Have alpha, betaHave alpha, beta--1 (cardiac), and beta1 (cardiac), and beta--2 (respiratory) 2 (respiratory) activitiesactivitiesEpinephrine (Adrenalin, Asmolin)Epinephrine (Adrenalin, Asmolin)
Nonselective betaNonselective beta--adrenergic drugsadrenergic drugsHave both betaHave both beta--1 and beta1 and beta--2 effects2 effectsIsoproterenol inhalation aerosol (Isuprel)Isoproterenol inhalation aerosol (Isuprel)
Selective betaSelective beta--2 receptor drugs2 receptor drugsAct primarily on betaAct primarily on beta--2 receptors in the lungs 2 receptors in the lungs Albuterol (Proventil, Ventolin)Albuterol (Proventil, Ventolin)
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Xanthine DerivativesXanthine DerivativesXanthine drugs include caffeine, theophylline, Xanthine drugs include caffeine, theophylline, and theobromineand theobromine
ActionsActionsRelax smooth muscle (particularly bronchial Relax smooth muscle (particularly bronchial smooth muscle)smooth muscle)Stimulate cardiac muscle and CNSStimulate cardiac muscle and CNSIncrease diaphragmatic contractilityIncrease diaphragmatic contractilityPromote diuresis through increased renal Promote diuresis through increased renal perfusionperfusion
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Mosby, Inc. items and derived items © 2007, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
55
Other Respiratory DrugsOther Respiratory DrugsProphylactic asthmatic agentsProphylactic asthmatic agents
Cromolyn sodium (Intal)Cromolyn sodium (Intal)
Aerosol corticosteroid agentsAerosol corticosteroid agentsBeclomethasone dipropionate (Vanceril inhaler, Beclovent)Beclomethasone dipropionate (Vanceril inhaler, Beclovent)
Muscarinic antagonistsMuscarinic antagonistsIpratropium (Atrovent)Ipratropium (Atrovent)
AntileukotrienesAntileukotrienesMontelukast (Singulair)Montelukast (Singulair)
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Mucokinetic DrugsMucokinetic Drugs
Move respiratory secretions and sputum along Move respiratory secretions and sputum along tracheobronchial treetracheobronchial tree
Alter consistency of secretions so that they can Alter consistency of secretions so that they can more easily be removed from the bodymore easily be removed from the body
Diluents (water, saline)Diluents (water, saline)Expectorants (Mucomyst)Expectorants (Mucomyst)
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
OxygenOxygenTreatment of hypoxia and hypoxemiaTreatment of hypoxia and hypoxemia
Colorless, odorless, and tasteless gas Colorless, odorless, and tasteless gas essential for sustaining lifeessential for sustaining life
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Mosby, Inc. items and derived items © 2007, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
56
Respiratory StimulantsRespiratory StimulantsDirect stimulants (analeptics)Direct stimulants (analeptics)
Act on medullary center of brainAct on medullary center of brainIncrease rate and depth of respirationsIncrease rate and depth of respirations
Reflex respiratory stimulantsReflex respiratory stimulantsSpirits of ammonia only inhalation drug given as a Spirits of ammonia only inhalation drug given as a reflex respiratory stimulantreflex respiratory stimulantAdministered during cases of faintingAdministered during cases of fainting
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Respiratory DepressantsRespiratory DepressantsIncludes opium and barbiturate groupsIncludes opium and barbiturate groups
Respiratory depression is a common side Respiratory depression is a common side effect effect
Seldom given to intentionally inhibit rate and Seldom given to intentionally inhibit rate and depth of respirationdepth of respiration
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Cough SuppressantsCough Suppressants
Cough is a protective reflex to expel harmful irritantsCough is a protective reflex to expel harmful irritants
It may be:It may be:Productive (removes airway secretions)Productive (removes airway secretions)Nonproductive (dry and irritating)Nonproductive (dry and irritating)
Antitussive agentsAntitussive agentsNarcotic agents (codeine)Narcotic agents (codeine)Nonnarcotic agents Nonnarcotic agents
•• Benzonatate (Tessalon)Benzonatate (Tessalon)
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Mosby, Inc. items and derived items © 2007, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
57
AntihistaminesAntihistaminesChemical mediator in most body tissuesChemical mediator in most body tissues
Highest in the skin, lungs, and GI tractHighest in the skin, lungs, and GI tract
Body releases histamine if exposed to antigen Body releases histamine if exposed to antigen
Antihistamines compete with histamine for receptor Antihistamines compete with histamine for receptor sitessites
Prevent action of histaminePrevent action of histamine
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
AntihistaminesAntihistaminesH 1 receptorsH 1 receptors
Act primarily on blood vessels and bronchiolesAct primarily on blood vessels and bronchioles
H 2 receptorsH 2 receptorsAct mainly on GI tractAct mainly on GI tract
Anticholinergic or atropineAnticholinergic or atropine--like actionlike action
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
AntihistaminesAntihistaminesPrimary clinical use is for allergic reactionsPrimary clinical use is for allergic reactions
Also for motion sickness, sedative, antiemeticAlso for motion sickness, sedative, antiemetic
ExamplesExamplesDimenhydrinate (Dramamine) Dimenhydrinate (Dramamine) Diphenhydramine (Benadryl)Diphenhydramine (Benadryl)Promethazine (Phenergan)Promethazine (Phenergan)
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Mosby, Inc. items and derived items © 2007, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
58
SerotoninSerotoninNaturally occurring vasoconstrictorNaturally occurring vasoconstrictor
In platelets and in cells of brain and intestineIn platelets and in cells of brain and intestineSerotonin is not administered as a drugSerotonin is not administered as a drugHas a major influence on other drugs and some Has a major influence on other drugs and some disease statesdisease states
•• Helpful in repairing damaged blood vesselsHelpful in repairing damaged blood vessels•• Stimulates smooth muscle contractionStimulates smooth muscle contraction•• Acts as a neurotransmitter in the CNSActs as a neurotransmitter in the CNS
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
AntiserotoninsAntiserotoninsAntiserotonins (serotonin antagonists) work Antiserotonins (serotonin antagonists) work to inhibit responses to serotonin and its to inhibit responses to serotonin and its influence on other drugs and disease statesinfluence on other drugs and disease states
Vascular headache, allergic disorder Vascular headache, allergic disorder treatmenttreatment
Cyproheptadine (Periactin)Cyproheptadine (Periactin)Methysergide maleate (Sansert)Methysergide maleate (Sansert)
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Drugs Affecting the GI SystemDrugs Affecting the GI SystemAntacids (AlkaAntacids (Alka--Seltzer)Seltzer)
Antiflatulents (Mylicon)Antiflatulents (Mylicon)
Digestants (Pancrease)Digestants (Pancrease)
Emetics (syrup of ipecac)Emetics (syrup of ipecac)
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Mosby, Inc. items and derived items © 2007, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
59
Drugs Affecting the GI SystemDrugs Affecting the GI System
Antiemetics Antiemetics Compazine, PhenerganCompazine, Phenergan
Cytoprotective agentsCytoprotective agentsProtect cells from damageProtect cells from damageCytotec, CarafateCytotec, Carafate
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Drugs Affecting the GI SystemDrugs Affecting the GI System
H2 receptor antagonists H2 receptor antagonists Reduce volume and acidity of gastric acidReduce volume and acidity of gastric acidZantac, Tagamet, PepcidZantac, Tagamet, Pepcid
Proton pump inhibitorsProton pump inhibitorsTreat symptomatic gastroesophageal reflux Treat symptomatic gastroesophageal reflux disease, esophagitisdisease, esophagitisNexium, Prevacid, Prilosec, AciphexNexium, Prevacid, Prilosec, Aciphex
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Drugs Affecting the Lower GI TractDrugs Affecting the Lower GI Tract
LaxativesLaxativesConstipation causes: Neurological disease, Constipation causes: Neurological disease, pregnancy, rectal disorders, surgery, drug pregnancy, rectal disorders, surgery, drug poisoningpoisoningEpsom salt, Dulcolax, ColaceEpsom salt, Dulcolax, Colace
AntidiarrhealsAntidiarrhealsAdsorbents (PeptoAdsorbents (Pepto--Bismol)Bismol)Anticholinergics (Donnatal)Anticholinergics (Donnatal)Opiates (paregoric)Opiates (paregoric)Other (Lomotil, Imodium)Other (Lomotil, Imodium)
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Mosby, Inc. items and derived items © 2007, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
60
Drugs Affecting the EyeDrugs Affecting the Eye
Antiglaucoma agentsAntiglaucoma agentsPilocarpine, acetazolamidePilocarpine, acetazolamide
Mydriatic and cycloplegic agentsMydriatic and cycloplegic agentsTreat inflammation, relieve painTreat inflammation, relieve painAtropine, homatropine opthalmic solutionAtropine, homatropine opthalmic solution
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Drugs Affecting the EyeDrugs Affecting the Eye
Antiinfective/antiinflammatory agentsAntiinfective/antiinflammatory agentsTreat conjunctivitis, sty, keratitisTreat conjunctivitis, sty, keratitis
Topical anesthetic agentsTopical anesthetic agentsPrevent pain, rapid onsetPrevent pain, rapid onsetProparacaine HCl, tetracaine HClProparacaine HCl, tetracaine HCl
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Drugs Affecting the EarDrugs Affecting the EarAntibiotics for infectionAntibiotics for infection
ChloramphenicolChloramphenicol
Steroid/antibiotic combinationsSteroid/antibiotic combinationsSuperficial bacterial infectionsSuperficial bacterial infectionsCortisporin OticCortisporin Otic
Miscellaneous preparationsMiscellaneous preparationsTreat ear wax, fungal infections, inflammationTreat ear wax, fungal infections, inflammation
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Mosby, Inc. items and derived items © 2007, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
61
Drugs Affecting the Endocrine SystemDrugs Affecting the Endocrine System
Endocrine system works to control and Endocrine system works to control and integrate body functionsintegrate body functions
Natural chemicals (hormones) are produced Natural chemicals (hormones) are produced by endocrine glandsby endocrine glands
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Drugs Affecting the PituitaryDrugs Affecting the Pituitary
Anterior and posterior pituitary gland hormones Anterior and posterior pituitary gland hormones regulate secretion of other hormonesregulate secretion of other hormones
Anterior pituitary drugsAnterior pituitary drugsTreat growth failure in children caused by growth Treat growth failure in children caused by growth hormone deficiencyhormone deficiency
Posterior pituitary drugsPosterior pituitary drugsTreat symptoms of diabetes insipidus due to Treat symptoms of diabetes insipidus due to antidiuretic hormone deficiencyantidiuretic hormone deficiency
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Drugs Affecting the Thyroid Drugs Affecting the Thyroid
Thyroid hormone controls rate of metabolic Thyroid hormone controls rate of metabolic processesprocesses
Required for normal growth and developmentRequired for normal growth and development
Parathyroid hormone regulates level of Parathyroid hormone regulates level of ionized calcium in blood through:ionized calcium in blood through:
Release of calcium from boneRelease of calcium from boneAbsorption of calcium from the intestineAbsorption of calcium from the intestineRate of excretion of calcium by the kidneysRate of excretion of calcium by the kidneys
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Mosby, Inc. items and derived items © 2007, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
62
Thyroid Gland DisordersThyroid Gland DisordersGoiterGoiter
Enlargement of thyroidEnlargement of thyroid
HypothyroidismHypothyroidismThyroid hormone deficiencyThyroid hormone deficiency
HyperthyroidismHyperthyroidismThyroid hormone excessThyroid hormone excess
Drugs to treat Drugs to treat hypothyroidism and hypothyroidism and prevent goitersprevent goiters
Thyroid (Synthroid)Thyroid (Synthroid)Iodine products Iodine products LevothyroxineLevothyroxine
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Parathyroid DisordersParathyroid DisordersHypoparathyroidism and hyperparathyroidismHypoparathyroidism and hyperparathyroidism
Drugs to treat hyperparathyroidismDrugs to treat hyperparathyroidismVitamin DVitamin DCalcium supplementsCalcium supplements
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Drugs Affecting the Adrenal CortexDrugs Affecting the Adrenal Cortex
Adrenal cortex secretes steroid hormonesAdrenal cortex secretes steroid hormonesGlucocorticoids (cortisol)Glucocorticoids (cortisol)
•• Raise blood glucoseRaise blood glucose•• Deplete tissue proteinsDeplete tissue proteins•• Suppress the inflammatory reactionSuppress the inflammatory reaction
Mineralocorticoids (primarily aldosterone)Mineralocorticoids (primarily aldosterone)•• Regulate electrolyte and water balanceRegulate electrolyte and water balance
Sex hormones Sex hormones •• Little physiological effect under normal circumstancesLittle physiological effect under normal circumstances
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Mosby, Inc. items and derived items © 2007, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
63
Drugs Affecting the PancreasDrugs Affecting the Pancreas
Hormones of the pancreasHormones of the pancreasInsulinInsulin
•• Primary hormone that regulates glucose metabolismPrimary hormone that regulates glucose metabolism
GlucagonGlucagon•• Stimulates liver to break down glycogen so that glucose Stimulates liver to break down glycogen so that glucose
is released into the bloodis released into the blood•• Also inhibits uptake of glucose by muscle and fat cellsAlso inhibits uptake of glucose by muscle and fat cells
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Drugs Affecting the PancreasDrugs Affecting the PancreasInsulin PreparationsInsulin Preparations
Rapid actingRapid actingInsulin lisproInsulin lisproInsulum aspartInsulum aspart
Short actingShort actingRegularRegular
Intermediate actingIntermediate actingLente InsulinLente InsulinNPH InsulinNPH Insulin
Long actingLong actingUltralenteUltralenteInsulin glargineInsulin glargine
Oral Hypoglycemic AgentsOral Hypoglycemic AgentsAmarylAmarylGlucophageGlucophageGlucotrolGlucotrolMicronaseMicronase
Oral Combination AgentsOral Combination AgentsGlucovanceGlucovanceMetaglipMetaglipAvandametAvandamet
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Drugs Affecting the PancreasDrugs Affecting the Pancreas
Hyperglycemic AgentsHyperglycemic AgentsGlucagonGlucagonDiazoxide (Proglycem)Diazoxide (Proglycem)DextroseDextroseOral glucose (Glutose, InstaOral glucose (Glutose, Insta--Glucose)Glucose)
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Mosby, Inc. items and derived items © 2007, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
64
Drugs Affecting the Reproductive SystemDrugs Affecting the Reproductive System
Includes synthetic and natural substancesIncludes synthetic and natural substances
HormonesHormonesFemaleFemaleMaleMale
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Female Sex HormonesFemale Sex HormonesTwo hormones secreted by ovary:Two hormones secreted by ovary:
EstrogenEstrogenProgesteroneProgesterone
Supplemental estrogen indicated for:Supplemental estrogen indicated for:Estrogen deficiency or replacementEstrogen deficiency or replacementTreatment of breast cancerTreatment of breast cancerProphylaxis for osteoporosis in postmenopausal womenProphylaxis for osteoporosis in postmenopausal women
Progesterone (and synthetic progestins) used to:Progesterone (and synthetic progestins) used to:Treat hormonal imbalanceTreat hormonal imbalanceTreat endometriosisTreat endometriosisTreat specific cancersTreat specific cancersPrevent pregnancy when properly usedPrevent pregnancy when properly used
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Oral ContraceptivesOral ContraceptivesOral contraception most effective form of birth Oral contraception most effective form of birth controlcontrol
Commonly known as Commonly known as ““the pillthe pill””Combination of estrogen and progesterone that Combination of estrogen and progesterone that results in suppression of ovulationresults in suppression of ovulation
Available in several different formsAvailable in several different forms
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Mosby, Inc. items and derived items © 2007, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
65
Ovulatory Stimulants and Infertility DrugsOvulatory Stimulants and Infertility Drugs
Absence of ovulation (anovulation) may be a Absence of ovulation (anovulation) may be a pathological condition in women with pathological condition in women with abnormal bleeding or infertilityabnormal bleeding or infertility
Sometimes treated with:Sometimes treated with:GonadotropinsGonadotropinsThyroid preparationsThyroid preparationsEstrogenEstrogenSynthetic agentsSynthetic agents
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Drugs Affecting the Drugs Affecting the Male Reproductive SystemMale Reproductive System
Testosterone therapyTestosterone therapyIndicated for treatment of:Indicated for treatment of:
•• Hormone deficiency (e.g., testicular failure)Hormone deficiency (e.g., testicular failure)•• ImpotenceImpotence•• Delayed pubertyDelayed puberty•• Female breast cancerFemale breast cancer•• AnemiaAnemia
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Drugs Affecting Sexual BehaviorDrugs Affecting Sexual Behavior
Drugs that impair libido and sexual Drugs that impair libido and sexual gratificationgratification
Includes some antihypertensives, antihistamines, Includes some antihypertensives, antihistamines, antispasmodics, sedatives, tranquilizersantispasmodics, sedatives, tranquilizers
Drugs that enhance libido and sexual Drugs that enhance libido and sexual gratificationgratification
Levodopa (LLevodopa (L--dopa)dopa)Sildenafil (Viagra)Sildenafil (Viagra)
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Mosby, Inc. items and derived items © 2007, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
66
Drugs Used in Neoplastic DiseasesDrugs Used in Neoplastic Diseases
Antineoplastic agentsAntineoplastic agentsUsed in cancer chemotherapy to prevent Used in cancer chemotherapy to prevent proliferation of malignant cellsproliferation of malignant cells
•• Do not directly kill tumor cellsDo not directly kill tumor cells•• Interfere with cell reproduction or replication Interfere with cell reproduction or replication •• ExamplesExamples
AdrucilAdrucilMustargenMustargenAmethopterinAmethopterin
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
AntibioticsAntibioticsTreat local or systemic infectionTreat local or systemic infection
Kill or suppress growth of microorganisms Kill or suppress growth of microorganisms Disrupt bacterial cell wallDisrupt bacterial cell wallDisturb functions of cell membraneDisturb functions of cell membraneInterfere with cellInterfere with cell’’s metabolic functionss metabolic functions
Includes:Includes:PenicillinsPenicillinsCephalosporins and related productsCephalosporins and related productsMacrolide antibioticsMacrolide antibioticsTetracyclinesTetracyclinesMiscellaneous antibiotic agents Miscellaneous antibiotic agents
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Antifungal DrugsAntifungal DrugsSome fungi are always present in bodySome fungi are always present in body
Mouth, skin, intestines, and vaginaMouth, skin, intestines, and vaginaPrevented from multiplying through competition Prevented from multiplying through competition from bacteria and from actions of the immune from bacteria and from actions of the immune systemsystemInfection occurs when person becomes Infection occurs when person becomes immunocompromisedimmunocompromisedTinactin, Diflucan, MycostatinTinactin, Diflucan, Mycostatin
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Mosby, Inc. items and derived items © 2007, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
67
Antiviral DrugsAntiviral DrugsFew effective drugs to treat minor viral infectionsFew effective drugs to treat minor viral infections
Viral infections range from harmless (e.g., warts) to Viral infections range from harmless (e.g., warts) to serious diseasesserious diseases
Often have toxic effectsOften have toxic effects
Acyclovir (Zovirax)Acyclovir (Zovirax)Zidovudine (Retrovir)Zidovudine (Retrovir)Lamivudine; zidovudine (Combivir)Lamivudine; zidovudine (Combivir)
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Protease InhibitorsProtease InhibitorsComplete mechanism of action not clearComplete mechanism of action not clear
Appear to inhibit replication of retroviruses (e.g., Appear to inhibit replication of retroviruses (e.g., HIV) in acute and chronically infected cellsHIV) in acute and chronically infected cells
Side effects and adverse reactionsSide effects and adverse reactions
Indinavir (Crixivan)Indinavir (Crixivan)
Ritonavir (Norvir)Ritonavir (Norvir)
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
AnalgesicAnalgesic--Antipyretic DrugsAntipyretic DrugsAntipyretics reduce feverAntipyretics reduce fever
AnalgesicAnalgesic--antipyretic drugs work by reversing the antipyretic drugs work by reversing the effect of the pyrogen on the hypothalamus effect of the pyrogen on the hypothalamus
Analgesics act on peripheral pain receptors to Analgesics act on peripheral pain receptors to block activationblock activation
AcetaminophenAcetaminophenAspirinAspirin
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Mosby, Inc. items and derived items © 2007, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
68
Nonsteroidal Antiinflammatory DrugsNonsteroidal Antiinflammatory Drugs
Aspirin is the prototype of the NSAIDsAspirin is the prototype of the NSAIDsInhibit enzymes so that prostaglandins Inhibit enzymes so that prostaglandins (substances that promote inflammation and pain) (substances that promote inflammation and pain) are not formedare not formedAspirinAspirinIbuprofenIbuprofenNaproxenNaproxenKetorolacKetorolacCelecoxibCelecoxib
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Drugs Affecting theDrugs Affecting theImmunological SystemImmunological System
ImmunosuppressantsImmunosuppressantsAntirejection, anticancer, Antirejection, anticancer, corticosteroid drugscorticosteroid drugs
Immunomodulating Immunomodulating agentsagents
SerumsSerumsVaccinesVaccines
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
ConclusionConclusionTo ensure maximum effectiveness and To ensure maximum effectiveness and
reduce the potential for harm, the paramedic reduce the potential for harm, the paramedic must have a thorough understanding of drugs must have a thorough understanding of drugs
and their actions before they are and their actions before they are administered.administered.
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Mosby, Inc. items and derived items © 2007, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
69
Questions?Questions?
Copyright © 2007, 2006, 2001, 1994 by Mosby, Inc., an affiliate of Elsevier Inc.
Mosby, Inc. items and derived items © 2007, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.